|
시장보고서
상품코드
1967822
심장 리듬 관리 디바이스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Cardiac Rhythm Management Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
심장 리듬 관리 디바이스 시장 규모는 2025년 279억 5,000만 달러에서 2034년에는 449억 8,000만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 5.43%로 성장할 전망입니다.
심박조율기, 이식형 제세동기(ICD), 심장재동기화 치료기기를 포함한 세계 심장리듬관리(CRM) 시장은 고령화 및 부정맥 스크리닝 확대에 따라 지속적으로 성장하고 있습니다. 장치의 소형화, 배터리 수명 연장, 무연 공간 제조 기술의 발전으로 임상 도입이 확대되고 있으며, 원격 모니터링 기능의 향상으로 이식 후 관리가 개선되고 있습니다. 또한 심혈관 질환의 유병률 증가와 신흥 시장에서의 심장 질환에 대한 접근성 개선이 성장을 지원하고 있습니다.
주요 성장 요인으로는 인구 고령화, 심부전 및 부정맥 유병률 증가, 진단 프로세스 개선, 기기 치료에 대한 보험 적용 범위 확대 등을 꼽을 수 있습니다. 기술 혁신(리드리스 페이싱, 피하삽입형 ICD, MRI 지원 장치, 첨단 텔레메트리)은 시술시 합병증을 줄이고, 환자의 삶의 질을 향상시킵니다. 또한 디지털 헬스 플랫폼 및 데이터 분석과의 상호운용성을 통해 조기 개입 및 치료 관리의 최적화를 가능하게 하고, 임상의의 현대적 CRM 시스템 선호도에 영향을 미치고 있습니다.
향후 전망은 개인화 치료, 지속적인 소형화, 원격 환자 관리와의 통합에 중점을 둘 것입니다. 무심실 다실 심박조율기, 장수명 배터리 또는 에너지수확기술 솔루션, AI 기반 부정맥 감지 기술이 차세대 제품의 형태를 결정하게 될 것입니다. 신흥 시장에서는 인프라와 전문의 확충에 따른 매출 증가가 예상됩니다. 가격 압력, 규제 당국의 감시 강화, 저침습적 대체요법과의 경쟁으로 인해 제조업체는 장기적인 성장을 유지하기 위해 임상적 차별화, 결과 데이터, 가치 기반 계약에 집중해야 합니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 심장 리듬 관리 디바이스 시장 : 제품별
제5장 세계의 심장 리듬 관리 디바이스 시장 : 용도별
제6장 세계의 심장 리듬 관리 디바이스 시장 : 최종 사용별
제7장 세계의 심장 리듬 관리 디바이스 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSA 26.03.24The Cardiac Rhythm Management Devices Market size is expected to reach USD 44.98 Billion in 2034 from USD 27.95 Billion (2025) growing at a CAGR of 5.43% during 2026-2034.
The global cardiac rhythm management (CRM) market, encompassing pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy devices, has expanded due to aging populations and greater screening for arrhythmias. Advances in device miniaturization, battery longevity, and leadless pacemaker technologies have broadened clinical adoption, while remote monitoring capabilities have improved post-implant care. Growth has been further supported by rising cardiovascular disease prevalence and better access to cardiac care in emerging markets.
Major growth drivers include demographic aging, increasing prevalence of heart failure and arrhythmias, improved diagnostic pathways, and reimbursement expansions for device therapies. Technological innovations-leadless pacing, subcutaneous ICDs, MRI-conditional devices, and enhanced telemetry-reduce procedural complications and enhance patient quality of life. Additionally, interoperability with digital health platforms and data analytics enables earlier intervention and optimized therapy management, influencing clinician preference toward modern CRM systems.
Future outlook emphasizes personalized therapies, continued miniaturization, and integration with remote patient management. Leadless multi-chamber pacing, longer-life batteries or energy-harvesting solutions, and AI-driven arrhythmia detection will shape next-generation offerings. Emerging markets will contribute incremental sales as infrastructure and trained specialists expand. Pricing pressures, regulatory scrutiny, and competition from minimally invasive alternatives will require manufacturers to focus on clinical differentiation, outcomes data, and value-based contracting to sustain long-term growth.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Pacemakers
- Defibrillators
- Cardiac Resynchronization Therapy Devices
By Application
- Congestive Heart Failure
- Arrhythmias
- Bradycardia
- Tachycardia
- Other Applications
By End Use
- Hospitals
- Cardiac Care Centers
- Ambulatory Surgical Centers
- Other End Use
COMPANIES PROFILED
- Abbott Laboratories, Abiomed Inc, AMI Italia Srl, Asahi Kasei Corporation, Biotronik SE Co KG, Boston Scientific Corporation, BPL Medical Technologies, CU Medical Inc, Defibtech LLC, LivaNova plc, Medico GmbH
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Pacemakers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Cardiac Resynchronization Therapy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Congestive Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Arrhythmias Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Bradycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Tachycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY END USE 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End Use
- 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Cardiac Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product
- 7.2.2 By Application
- 7.2.3 By End Use
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product
- 7.3.2 By Application
- 7.3.3 By End Use
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product
- 7.4.2 By Application
- 7.4.3 By End Use
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product
- 7.5.2 By Application
- 7.5.3 By End Use
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product
- 7.6.2 By Application
- 7.6.3 By End Use
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Abbott Laboratories
- 9.2.2 Abiomed Inc
- 9.2.3 AMI Italia S.R.L
- 9.2.4 Asahi Kasei Corporation
- 9.2.5 Biotronik SE & Co. KG
- 9.2.6 Boston Scientific Corporation
- 9.2.7 BPL Medical Technologies
- 9.2.8 CU Medical Inc
- 9.2.9 Defibtech LLC
- 9.2.10 LivaNova Plc
- 9.2.11 Medico GmbH
